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Abstract 
Background: Observational studies have shown that body mass index (BMI) is positively 
associated with asthma. However, observational data are prone to confounding and reverse 
causation. In Mendelian randomization, genetic variants are used as un-confounded markers 
of exposures to examine causal effects. We examined the causal effect of BMI on asthma, 
hay fever, allergic sensitization, serum total immunoglobulin E (IgE), forced expiratory 
volume in one second (FEV1), and forced vital capacity (FVC).  
Methods: We included 490,497 participants in the observational and 162,124 participants in 
the genetic analyses. A genetic risk score (GRS) was created using 26 BMI-associated single 
nucleotide polymorphisms (SNPs). Results were pooled in meta-analyses and expressed as 
odds ratios (ORs) or β-estimates with 95% confidence interval (CI).  
Results: The GRS was significantly associated with asthma (OR=1.009; 95% CI: 1.004, 
1.013), but not with hay fever (OR= 0.998; 95% CI: 0.994, 1.002), or allergic sensitization 
(OR=0.999; 95% CI: 0.986, 1.012) per BMI-increasing allele. The GRS was significantly 
associated with decrease in FEV1: β=-0.0012 (95% CI: -0.0019, -0.0006) and FVC: β=-
0.0022 (95% CI: -0.0031, -0.0014) per BMI-increasing allele. Effect sizes estimated by 
instrumental variable analyses were OR=1.07 (95% CI: 1.03, 1.10) for asthma, a 9 ml 
decrease in FEV1 (95% CI: 2.0-15 ml decrease), and a 16 ml decrease in FVC (95% CI: 7.0-
24 ml decrease) per 1 kg/m2 higher BMI. 
Conclusions: The results support the conclusion that increasing BMI is causally related to 
higher prevalence of asthma and decreased lung function, but not with hay fever or 
biomarkers of allergy. 
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Introduction 
Overweight and obesity are in reported observational studies consistently associated with 
increased prevalence of asthma and (1), to some extent, decreased lung function (2), while 
the association with hay fever and allergic sensitization is less clear (3-5). Overweight and 
obesity may affect the lungs in several ways, e.g., through inflammation that may predispose 
to asthma or through a mechanical effect on lung function. Mechanically, increased body 
mass index (BMI) may lead to decreased static lung volumes (6), and breathing with smaller 
tidal volumes which may leave some of the cross-bridged myosin-actin in the airways 
unbroken (7), thereby further narrowing the airways (8). In addition, the overweight/obesity-
related low-grade inflammation may affect lung function and the risk of asthma (9). It is 
likely that other factors associated with overweight and obesity such as dyslipidaemia and 
increased mast cell activity are also implicated in the pathogenesis of asthma and decreased 
lung function. E.g., an increased number of mast cells has been found in adipose tissue, and 
mast cells participate in asthma by degranulation in response to allergen challenge (10). Upon 
activation, mast cells secrete peptidases such as tryptase (11,12). Tryptase may increase 
inflammation and remodeling of airway smooth muscles, and tryptase inhibition has been 
found to reduce airway inflammation.  
 However, inferring a causal relationship, e.g., between BMI and asthma, from 
such observational studies may be hampered by bias such as confounding and reverse 
causation. Mendelian randomization that is based on observational data is a method for 
making inferences about causal effects by using genetic instrumental variables (IV). The idea 
is that if we can replace the actual measured values of an exposure (which may be correlated 
with confounders etc.) by predicted values of the exposure (via the IV) that are related to the 
actual exposure but uncorrelated with confounders, we can get an un-confounded estimate. 
  
This has been used previously in a study of approximately 5000 children where a higher BMI 
was found to increase the risk of asthma (13). However, this has not been examined in adults. 
Mendelian randomization takes advantage of the random allocation of alleles from parent to 
child and is a method for examining and estimating possible causal relationships where 
genetic IVs with well-known effects on an exposure are used as proxies for that exposure 
(14). To be a valid instrument, the genetic variant must be associated with the exposure, it 
may only affect the outcome through the exposure, and it cannot be associated with any 
unmeasured confounders. 
 We used a genetically determined higher BMI to investigate and quantify the 
effect of adiposity on asthma, hay fever, biomarkers of allergy (IgE antibodies), and lung 
function in adults (≥16 years) according to the principles of Mendelian randomization. We 
included 26 SNPs, including the FTO rs9939609 (15), that are associated with BMI at 
genome-wide significance levels in a number of genome-wide association studies (GWAS) 
(16-28) previously validated in one of the included studies (29,30).  
 
Methods 
Study populations 
We used data on 490,497 participants of European ancestry and aged ≥16 years of whom 
162124 had data on all or most of the relevant SNPs from the following seven population-
based studies: the Danish Monitoring of trends and determinants in Cardiovascular Diseases 
(MONICA) study (the Monica10 study) (31), Health2006 (32), Health2008 (33), Inter99 
(34), the Study of Health in Pomerania (SHIP) (35), and SHIP-TREND (36), and the UK 
Biobank (more information in Supplementary Material, incl. Table S1) (37). Each study was 
approved by local Ethics Committees, and the participants gave their informed consent. 
  
 
Genotype 
We preselected 26 BMI-associated SNPs as listed in Table 1 (16-28). None of the cohorts 
used were in the discovery samples for these SNPs. Descriptions of the genotyping method 
within each study are provided in Supplementary Material. Minor allele frequencies (MAF) 
and Hardy–Weinberg equilibrium p-values are shown in Table S2. Some SNPs were in one 
or a few studies not in Hardy-Weinberg equilibrium at the 0.05 significance level, but except 
for two SNPs in the UK Biobank, all SNPs were in Hardy-Weinberg equilibrium at the 
Bonferroni-adjusted significance level (p<0.00027). Each SNP was classified according to 
the number of BMI-increasing alleles, i.e. 0, 1, or 2. A simple genetic risk score was 
calculated by adding the number of BMI-increasing alleles (38). In secondary analyses, we 
used a weighted genetic risk score with weights derived from studies different from our own 
(16-28). See individual weights in Table 1.  
 
BMI 
Height and weight were measured, and BMI was calculated as weight divided by height 
squared, expressed in kg/m2. 
 
Hay fever, asthma, allergic sensitization, and serum total IgE, FEV1, and FVC 
Information on hay fever and asthma was based on self-report (Supplementary Material incl. 
Table S3). Our first choice was lifetime/ever diagnoses. Allergic sensitization was defined as 
serum specific IgE positivity to at least one of a number of inhalant allergens (Supplementary 
Material incl. Table S3). Serum total IgE levels were measured by the IMMULITE 2000 
Allergy Immunoassay System in Inter99 Study, and by the Latex IgE test on the BN II 
  
Nephelometer (Dade Behring Marburg GmbH, Marburg, Germany) in the SHIP Study (39). 
FEV1 and FVC were measured with spirometry. More details are provided in the 
Supplementary Material. For additional analyses in UK Biobank data only, we created 
subgroups of persons who had both asthma and hay fever (as a measure of ‘atopic’ asthma), 
asthma but not hay fever (as a measure of ‘non-atopic’ asthma), and not asthma or hay fever. 
 
Statistical analyses 
Statistical analyses were performed with SAS, version 9.4 (SAS Institute Inc., Cary, NC, 
USA), STATA, version 13 (StataCorp, College Station, TX, USA), and R-statistical package, 
version 3.2.3 for Windows (http://www.r-project.org/). The p-values are two-tailed, and 
statistical significance was defined as p<0.05, but the causality of associations was assessed 
by the strength of evidence rather than the size of the P-value only. For each of the studies, a 
dataset was prepared in accordance with the study protocol, and the data were analyzed by a 
pre-prepared Stata-script that was adapted to each study. To obtain a normal distribution, 
serum total IgE was transformed by the natural logarithm (log). Except for first stage 
analyses only (e.g., Figure 3) where BMI was transformed to the logarithm of two, the 
reported data are according to BMI not log-transformed (incl. first stage estimates to be used 
in IV-analyses). The results from each study were meta-analyzed with fixed effects analyses 
and heterogeneity assessed by the I2 test. Effect estimates are presented as β-coefficients or 
odds ratios with 95% confidence intervals (95% CI).  
 
Observational analyses 
Observational, i.e. the BMI-outcome associations, analyses were performed using logistic and 
linear regression analyses that were adjusted for sex and age, and in the FEV1 and FVC 
  
analyses also for height. We also compared results from observational analyses considering 
only those from UK Biobank that were included in the MR analyses to the whole UK 
Biobank sample.  
 
Mendelian randomization analyses 
The SNP data for each study is shown in Table S1. We created a SNP-score which is a single 
variable that summarizes multiple SNPs in a univariate score. Our primary analyses rely on a 
simple SNP-score that counts the number of BMI-increasing alleles whereas in a weighted 
SNP-score, each SNP contributes a weight that reflects the effect of the SNP on BMI. The ‘F-
value’ is an analogue of the F-statistic for the joint significance of the SNP/SNP-score in the 
first stage regression. The F-value is an indicator of statistical power in the MR analysis (40). 
In the UK Biobank study, the F-value for the SNP-score was 1185 for BMI. The single-SNP 
F-values ranged from 1 to 397 in the UK Biobank data. The rs1424233 and rs11847697 SNPs 
had F-values below 10. Analyses excluding the three SNPs with signs of Hardy-Weinberg 
disequilibrium in the UK Biobank Study were also performed. The requirement that the 
instrument is not associated with unmeasured confounders can only be falsified, but to 
substantiate the assumption, we assessed the associations between each single-SNP and age, 
sex, smoking status, and alcohol status. 
 Mendelian randomization analyses (first stage: SNP-BMI, second stage: SNP-
outcome) were performed using logistic and linear regression analyses that were adjusted for 
sex and age, and in the FEV1 and FVC analyses also for height. To obtain a normal 
distribution, serum total IgE was transformed by the natural logarithm (log).  
 IV analyses were performed by using the R packages 
“MendelianRandomization” and “ivpack”, and graphs were made by the “rmeta” package in 
  
R. To obtain estimates expressed per 1 kg/m2 higher BMI, we used the untransformed BMI in 
the first stage analysis. As the primary IV analyses, we performed a one-sample analysis, 
where all relevant studies were included in both the first and second stage analysis. 
Secondarily, we performed two-sample IV-analyses where the first and second stage sample 
had no overlap: All studies except for the UK Biobank Study provided data for the first stage 
and UK Biobank alone provided data for the second stage analysis. To assess potential 
pleiotropy, we also performed MR Egger regression and median regression analyses (41). 
    
Results 
Observational analyses 
Descriptive statistics for each study population are found in Table 2.  
  
In sex- and age-adjusted observational analyses (Figure 1), BMI was inversely and significantly 
associated with hay fever: OR=0.995 (95% CI: 0.994, 0.997, p <0.001) per 1 kg/m2 higher BMI and 
positively and significantly associated with asthma: OR=1.037 (95% CI: 1.035, 1.039, p<0.001) per 
1 kg/m2 higher BMI. BMI was positively but non-significantly associated with allergic sensitization 
with OR=1.007 (95% CI: 0.998, 1.016, p=0.131) per 1 kg/m2 higher BMI. BMI was positively and 
significantly associated with log(IgE): β=0.02 (95% CI: 0.01, 0.03, p<0.001) per 1 kg/m2 higher 
BMI (Figure 2). In general, the heterogeneity was low to modest and ranged from 0.0%-53.2%. 
BMI was inversely associated with FEV1 and FVC with β=-0.012 (95% CI: -0.013, -0.012, 
p<0.001) and β=-0.024 (95% CI: -0.025, -0.024, p<0.001), respectively per 1 kg/m2 higher BMI 
(these analyses were further adjusted for height) in fixed effect meta-analyses (Figure 2). The 
heterogeneity was substantial (both I2>90.0%). The study-specific estimates of observational 
analyses of the association between BMI, FEV1 and FVC are shown in Supplementary Figure S6. 
Random effect meta-analyses yielded for FEV1: β=-0.008 (95% CI: -0.012,-0.004, p=0.0002) and 
FVC: β=-0.019 (95% CI: -0.023,-0.014, p<0.0001). Applying a Bonferroni-correction (6 outcomes, 
p=0.05/6=0.0083) did not change the statistical significance in the observational analyses. The 
observational results considering only those from UK Biobank that were included in the MR 
analyses below compared to the whole UK Biobank sample showed similar results. The results of 
observational analyses excluding UK Biobank were largely similar (Supplementary Figures S2 and 
S4). 
 
Mendelian randomization analyses 
Figure 3 shows the associations of each SNP with the log2-transformed BMI and substantiates their 
use as valid instruments. Fixed effect meta-analyses of the age- and sex-adjusted association of the 
BMI-associated SNP-score and BMI showed significantly higher log2(BMI): β=0.007 (95% CI: 
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0.007, 0.008, p<0.0001) per BMI-increasing allele. However, there was substantial heterogeneity 
(I2=95.3%) and random effects meta-analysis showed: β=0.007 (95% CI: 0.006, 0.009, p<0.0001) 
per BMI-increasing allele. To justify the assumption that the instruments are not associated with 
unmeasured confounders (33,42), we assessed the associations between each single-SNP and the 
available possible confounders age (all p>0.007 in Kruskal-Wallis’ test), sex (all p>0.021 in the Χ2-
test), smoking status (all p>0.0009 in the Χ2-test), and alcohol status (all p>0.016 in the Χ2-test). No 
associations were statistically significant at the Bonferroni-adjusted significance level 
(p=0.05/(4*26)=0.00048), however.  
 In the primary, one-sample sex- and age-adjusted Mendelian randomization analyses 
(Figure 1), the SNP-score was positively and significantly associated with asthma: OR=1.009 (95% 
CI: 1.004, 1.013, p<0.001, I2=51.1%) per BMI-increasing allele. The results of MR-analyses 
excluding UK Biobank were largely similar (Supplementary Figures S1 and S3). Using a weighted 
SNP-score in the UK Biobank alone, we found for asthma: OR=1.068 (95% CI: 1.034, 1.104, 
p<0.001) per BMI-increasing allele. There was a high degree of consistency in the predicted effect 
of each single-SNP on asthma (Figure S5). IV-analysis yielded an OR=1.07 (95% CI: 1.03, 1.10) of 
asthma per 1 kg/m2 higher BMI. There was no clear evidence that the SNP score was associated 
with hay fever: OR=0.998 (95% CI: 0.994, 1.002, p=0.333, I2=0.0%) per BMI-increasing allele. 
Likewise, using a weighted SNP-score in the UK Biobank alone, we found for hay fever: OR=0.995 
(95% CI: 0.969, 1.022, p=0.711) per BMI-increasing allele. Alternative definitions of hay fever in 
UK Biobank data (See Supplementary) showed for those taking medication for hay fever at 
baseline: OR=1.006 (95% CI: 0.994, 1.018, p= 0.316, N=146072), with self-reported hay fever as 
serious illness at baseline: OR=1.000 (95% CI: 0.992, 1.009, p=0.908, N=146072), or persons with 
self-reported hay fever or allergic rhinitis at follow-up in 2015: OR=0.998 (95% CI: 0.990, 1.006, 
p=0.655, N=34556) for hay fever per BMI-increasing allele compared with the rest, respectively. 
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The SNP-score was non-significantly associated with allergic sensitization with OR=0.999 (95% 
CI: 0.986, 1.012, p=0.906, I2=0.0%) per BMI-increasing allele.  
 The BMI-increasing SNP-score was inversely associated with FEV1 and FVC with 
β=-0.0012 L (95% CI: -0.0019, -0.0006, p=0.011) and β=-0.0022 L (95% CI: -0.0031, -0.0014, 
p<0.001), respectively, per BMI-increasing allele in age-, sex- and height-adjusted analyses. 
Correspondingly, using a weighted SNP-score in the UK Biobank only, we found for FEV1: β=-
0.0089 L (95% CI: -0.0155, -0.0023, p=0.008) and for FVC: β=-0.0164 L (95% CI: -0.0249, -
0.0078, p<0.001) per BMI-increasing allele. IV-analyses showed a 9 ml decrease in FEV1 (95% CI: 
2.0-15 ml decrease) and a 16 ml decrease in FVC (95% CI: 7.0-24 ml decrease) per 1 kg/m2 higher 
BMI. The heterogeneity was low (all I2 <26.9%) in the analyses of the SNP-score vs. FEV1 and 
FVC, respectively. Fixed effects meta-analysis showed a non-significantly β=0.003 (95% CI: -
0.006, 0.012, p=0.547) higher log(IgE) per BMI-increasing allele with low heterogeneity (I2=0.0%). 
Except for the association between the SNP-score and FEV1, applying a Bonferroni-correction (6 
outcomes, p=0.05/6=0.0083) did not change the statistical significance in the main IV-analyses. 
Two-sample Mendelian randomization analyses of hay fever, asthma, FEV1, and FVC supported 
the one-sample results (Figure 1-2). We found little evidence of pleiotropy for the BMI-associated 
SNPs on asthma, as indicated by the MR Egger intercept test (p=0.069) and the Egger regression 
analysis showed an odds ratio of asthma: OR=1.09 (95% CI: 1.03, 1.15, p=0.002) per 1 kg/m2 
higher BMI (43). Likewise, median regression yielded an odds ratio of asthma: OR=1.05 (95% CI: 
1.01, 1.09, p=0.007) per 1 kg/m2 higher BMI.  
 Analyses excluding the three SNPs with signs of Hardy-Weinberg disequilibrium in 
the UK Biobank Study showed for hay fever: OR=0.999 (95% CI: 0.995, 1.003, p=0.544), asthma: 
OR=1.011 (95% CI: 1.006, 1.016, p=0.00003), and FEV1: β=-0.001 (95% CI: -0.002, -0.0004, 
p=0.004), and FVC: β=-0.003 (95% CI: -0.004, -0.001, p=0.0001) litre per BMI-increasing allele. 
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In additional analyses of the association between the genetic risk score and hay fever, we performed 
the analyses with and without the SHIP TREND Study. The estimate and confidence intervals were 
equal to the third decimal place. Also, we found that persons with both asthma and hay fever 
(‘atopic’ asthma) vs. persons with neither asthma nor hay fever had largely the same odds ratio per 
BMI-increasing allele as in the primary analyses where we compared those with asthma to those 
without asthma regardless of hay fever status. In comparison, persons who had asthma but not hay 
fever (‘non-atopic’ asthma) vs. persons with neither asthma nor hay fever had a slightly lower odds 
ratio per BMI-increasing allele that was not statistically significant.   
 
Discussion 
In a Mendelian randomization meta-analysis, we found that a genetically determined higher BMI 
was associated with a significantly higher prevalence of asthma and lower lung function (both 
FEV1 and FVC), but not with hay fever and allergy biomarkers. The observed positive association 
between BMI and asthma is in line with the results from the majority of previous studies (Table 3) 
(44-53), including a Mendelian Randomization study of close to 5,000 children where a higher BMI 
increased the risk of asthma in mid-childhood (13). A review by Baumann et al. concluded that the 
association between obesity and asthma was particularly seen for non-atopic asthma (54). However, 
our analysis in the UK Biobank sample using presence/absence of hay fever to define atopic/non-
atopic asthma could not fully corroborate that. A number of studies found no statistically significant 
associations between BMI and asthma (55-57).  
 The observed negative association between BMI and lung function is in line with a 
study by Ciprandi et al. comprising 268 individuals who found that lung function was significantly 
impaired in overweight and obese asthmatic patients, e.g., overweight patients, had double 
(OR=1.89) and obese patients had triple the risk (OR=3.17) of a pathological FEV1 compared to 
  13
normal-weight patients (58). Fenger et al. found in a study of 2308 adults that increasing adiposity 
was associated with decreasing lung function over a five year period in longitudinal study of 2308 
adults (2). A one standard deviation increase in BMI corresponded to a −78.5 ml and −113.6 ml 
five-year change in FEV1 and FVC, respectively, in men, and a −25.5 ml and −32.6 ml five-year 
change in FEV1 and FVC, in women, respectively.   
 The results from previous studies on BMI and hay fever are inconsistent (Table 4). 
Theobserved lack of association in the current study is in line with the conclusions from two 
research studies of 3047 adults and 3466 adolescents, respectively (57,59), and a review including 
50,086 individuals (54). However, several studies have found both inverse (51,52,58,60,61) and 
positive associations between BMI/overweight/obesity and hay fever (49,55,56,60,62,63).  
 Likewise, previous studies examining the association between obesity and allergic 
sensitization in adults have shown conflicting results (44). There are studies supporting a positive 
association (4,64,65) and studies reporting no or an inverse association between BMI and allergic 
sensitization (66-68). The observed non-significantly higher odds ratio of allergic sensitization for a 
higher BMI is in line with a study by Sybilski et al. who in almost 10000 adults found that obesity 
and overweight were not associated with the frequency of sensitization to aeroallergens (51). 
Likewise, Yao et al. found a statistically non-significant higher prevalence of allergic sensitization 
in 5,351 Taiwanese children (53). Somewhat in contrast, a study by Byberg et al. involving 617 
study participants found BMI in early childhood to be positively associated with atopic sensitization 
in later childhood (48). Also, in a study of 139 individuals, Lokaj-Berisha et al. found high BMI to 
be associated with atopy (50).  
 Strengths of the current study include the fact that the SNPs were preselected from 
GWAS studies of populations different from our own but of the same ethnicity. Since most of the 
SNPs had small individual effects, we constructed a genetic risk-score where the multidimensional 
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genetic data were collapsed into one variable. Risk-scores -as opposed to the individual variants- 
may be stronger instruments (69). Each SNP in the SNP-score had to fullfil the requirements for an 
IV in order for the score to be a valid instrument (70). All but two of the SNPs had F-values above 
10 in the UK Biobank data, and the F-value was 2000 for the SNP-score.  
 Limitations of the study include the low power in the analyses of allergic sensitization 
and serum total IgE compared with the power in the analyses of asthma, hay fever, and lung 
function. The hay fever variable in the UK Biobank included eczema which is a less specific 
variable for hay fever than most of the other studies. However, we assessed three additional hay 
fever variables from the UK Biobank with similar results which indicates that the misclassification 
did not seriously bias our results. The main weaknesses of the three additional hay fever variables 
were the fact that the first was measured at follow-up in 2015 in a subgroup only; the second only 
included participants who would classify their hay fever as a serious illness or disability; and the 
third additional hay fever variable was based on self-reported medication rather than doctor 
diagnosed hay fever. In addition, the definition of hay fever in the SHIP TREND Study differs. 
However, the estimate and confidence intervals of the association between the genetic risk score 
and hay fever were equal to the third decimal place which means that this potential misclassification 
did not seriously bias our results. 
 Causal inference may be distorted by a number of violators of the Mendelian 
randomization assumptions, e.g., pleiotropy where the genetic marker has diverse biological 
functions. This assumption may be more plausible for specific proteins or serum markers than for a 
general phenotype such as BMI. However, MR Egger and median regressions showed little sign of 
pleiotropy in the BMI-associated SNPs and asthma. There was also a high degree of consistency in 
the predicted effect of each single-SNP on asthma (Figure S5). Also, we found little evidence of 
associations between the included SNPs and the possible confounders, age, sex, smoking and 
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alcohol intake in the UK Biobank data. There were no obvious trends or consistencies regarding the 
SNPs with signs of Hardy-Weinberg disequilibrium, neither relating to the SNPs nor the studies, 
and we consider these chance findings. This was corroborated by analyses excluding the three SNPs 
in Hardy-Weinberg disequilibrium in the UK Biobank Study as listed in the results. Weak 
instrument bias is a particular concern in small studies when using genetic variants that explain only 
little variation in the risk factor (71). Weak instrument bias can be introduced in one-sample MR 
studies because the associations of the SNPs with the risk factor and outcome are correlated. The 
causal estimate will be biased in the direction of the observational association contrary to a two-
sample Mendelian randomization analysis where any weak instrument bias is in the direction of the 
null. Even so, in support of using an overlapping sample in the current study, the SNP-score was 
constructed from SNPs not discovered in the included studies, the SNP-score did not use (internal) 
weights, and it had a high F-value. The current study included the very large UK Biobank Study 
that had acceptable F-values for the large majority of the SNPs. The estimates in UK Biobank data 
were similar to the meta-analysis estimates for asthma, hay fever, and lung function. In addition, 
results from two-sample Mendelian randomization analyses of hay fever, asthma, FEV1, and FVC 
were almost identical to the one-sample analyses which means that weak instrument bias does not 
seriously bias our results. The results from using a weighted genetic risk score supported our 
findings from using a simple genetic risk score. 
 In conclusion, we found that genetically determined higher BMI was associated with a 
higher prevalence of asthma and lower lung function. Taken together with the traditional 
observational results and the existing evidence, the results are supportive of a positive causal 
relation between BMI and asthma and an inverse relation with FEV1 and FVC.  
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Figure 1. One- and two-sample IV analysis and fixed effects meta-analysis of the observational estimates of age- and 
sex-adjusted associations between BMI and hay fever, asthma, and allergic sensitization, respectively. The numbers of 
persons included in the two-sample IV analysis are shown as ‘number in first stage analysis’/‘number in second stage 
analysis’. Abbreviations: CI, confidence interval; BMI, body mass index; IV, instrumental variable. 
 
Figure 2. One- and two-sample IV analysis and fixed effects meta-analysis of the observational estimates of BMI 
(kg/m2) with FEV1 (litre), FVC (litre), and log(IgE). The IV estimates are generated from unadjusted first and second 
stage analyses. Units are noted in parentheses. The numbers of persons included in the two-sample IV analysis are 
shown as ‘number in first stage analysis’/‘number in second stage analysis’. Abbreviations: CI, confidence interval; 
BMI, body mass index; IV, instrumental variable. 
Figure 3. Age- and sex-adjusted associations of each BMI-associated SNP and the log2-transformed BMI. 
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